The Secret Behind the Salamander That Regrows an Entire Limb

Introduction: the animal that refuses to stay amputated

A power that has fascinated science for centuries

Cut off a salamander's leg, and it will grow a new one, perfectly functional, with the right bones, the right muscles, and the right digits, at the right size and in the right place. This power of regeneration, known to naturalists for centuries, still fascinates biologists today, because it touches on a fundamental question: why can some animals rebuild an entire limb, while humans, equipped with the same basic molecular ingredients, are completely unable to do so?

A study published in June 2025 in the journal Nature Communications offers fresh answers to this question, precisely identifying the molecular mechanisms that let the axolotl, a species of Mexican salamander widely studied in laboratories, know exactly which part of the body to rebuild, at what precise size, and in what exact location on the body.

The central role of retinoic acid

At the heart of this process lies a molecule well known in biology: retinoic acid, a derivative of vitamin A also found in many cosmetic creams marketed to humans. This substance plays a central role in the embryonic development of a great many animal species, including our own. In salamanders, scientists had long known that retinoic acid was involved in limb regeneration, but the precise mechanism that allowed this molecule to be dosed with such accuracy remained largely mysterious, despite decades of research on the subject.

This mystery was no small matter: understanding how a simple molecule can tell cells the difference between rebuilding a finger, a hand, or an entire arm represented one of the most stubborn puzzles in developmental biology. Researchers knew the answer lay somewhere in the chemistry of the wound site, without being able, until now, to describe the exact mechanism.

An enzyme that plays conductor

CYP26B1, the precision dosing enzyme

The major discovery of this study concerns an enzyme called CYP26B1. Contrary to what one might expect, this enzyme does not manufacture retinoic acid: it reduces the amount present at the wound site, with remarkable precision, down to exactly the level needed to rebuild the missing part. Researcher James Monaghan, whose work was highlighted by National Geographic among the year's standout discoveries, explains that it is the amount of retinoic acid present that tells cells precisely what they need to rebuild at that spot on the body.

This finding surprised the team itself. Researchers expected to find an additional production mechanism for retinoic acid at the wound site, capable of raising its concentration as needed. Instead, they found a reversed system: a targeted degradation enzyme, which starts from a high initial level and gradually reduces it down to the exact required value. This subtraction-based, rather than addition-based, mechanism offers an unexpected lesson in how nature solves problems of biological precision.

The higher the residual concentration of retinoic acid after the enzyme acts, the larger and more complex the regenerated structure will be: an entire arm requires more of this molecule than a simple hand, which in turn requires more than a single finger. This fine-tuned dosing system explains how the salamander manages to rebuild precisely the missing portion of the limb, neither more nor less, without ever regrowing an oversized or incomplete limb.

A gene that determines the final size

Alongside this chemical dosing mechanism sits a second genetic player: the Shox gene, already known in humans for its role in the growth of long bones. In salamanders, this same gene activates after an injury to orchestrate the reconstruction of the bone structures of the forming limb. Researchers believe that access to these precise genetic programs after an injury is what allows the animal to literally switch back on the instructions that were used to build the arm the first time, during its initial embryonic development.

This gene acts a bit like an invisible measuring stick, determining how far the new bone structure should extend before stopping. Without this precise regulation, the salamander could theoretically produce a limb that is too long, too short, or poorly proportioned. The fact that nature selected a rigorous system, combining both a chemical signal and a genetic signal, speaks to the sophistication of the regeneration process, long underestimated by science.

The combination of these two elements, the precise dosing of retinoic acid by the CYP26B1 enzyme and the targeted activation of the Shox gene, forms a kind of molecular blueprint that the salamander appears able to reread at will, unlike most other vertebrates.

Why humans cannot do the same thing

The same ingredients, but a different recipe

The most troubling part of this discovery is probably this: humans also possessretinoic acid, the CYP26B1 enzyme, and the Shox gene. We therefore have, in theory, the same basic molecular building blocks as the salamander. And yet, when a human loses a limb, these elements do not organize themselves the same way to rebuild the missing part. The difference does not lie in the presence or absence of these ingredients, then, but in how our bodies activate them, or rather fail to properly reactivate them after an amputation in adulthood.

This distinction is crucial for medical research: it means the goal is not to import exotic genes into the human genome, but to understand how to wake up biological capabilities that are already present, yet silenced over the course of evolution. A far more realistic prospect, even though it remains extraordinarily complex to put into practice.

The gap between theory and the clinic

Despite the enthusiasm sparked by these results, the researchers themselves stress the need for caution. Identifying the molecular mechanisms in salamanders is one thing; managing to reproduce them safely and in a controlled way in an adult human organism is another matter entirely, far more complex. The human body, with its far more sophisticated physiology, its distinct immune response, and its different healing processes, poses considerable obstacles to any attempt at directly transposing these mechanisms.

Nevertheless, this research opens up a serious theoretical avenue toward longer-term medical applications, notably for improving wound healing after severe trauma, or for exploring partial regeneration of damaged tissue, well before considering the complete regeneration of a human limb.

A discovery among the most notable of the year

Recognition beyond the academic circle

This research on regeneration in salamanders was highlighted by National Geographic among the major medical discoveries of 2025. This recognition illustrates the importance the scientific community and the general public place on this work, which touches on a universal question: how the body repairs itself after severe injury, a major medical concern for millions of amputees and severe trauma victims worldwide.

The choice of the axolotl as a study model is no accident. This species of salamander, native to Mexico and now threatened in the wild, has become a go-to laboratory animal for studying regeneration, thanks to its exceptional ability to rebuild not just its limbs but also certain internal organs, its spinal cord, and even parts of its heart or brain.

The next steps for research

Research teams, including the one led by Monaghan, now plan to deepen their understanding of the interactions between retinoic acid, the CYP26B1 enzyme, and the Shox gene, in order to determine whether targeted interventions could one day modulate these same pathways in mammals, initially for experimental purposes. This work fits into a broader research field devoted to regenerative medicine, which explores multiple parallel avenues for restoring damaged tissues and organs.

This convergence between fundamental biology and therapeutic prospects illustrates well why studying a creature as unusual as the axolotl continues to attract top-tier funding and researchers, decades after nineteenth-century naturalists first observed its regenerative abilities.

Conclusion: between wonder and scientific caution

What this discovery really changes

The study on limb regeneration in salamanders provides a precise answer to a question asked for generations: how does an organism know exactly what to rebuild after an amputation? The answer combines fine chemical dosing of retinoic acid, orchestrated by the enzyme CYP26B1, and activation of the Shox gene, which together dictate the size and nature of the structure to be regenerated.

This mechanistic understanding is a significant advance in fundamental biology, regardless of any immediate medical application. It enriches our knowledge of living organisms and of how certain species have, over the course of evolution, preserved repair capabilities that others, such as mammals, have largely lost.

A human application still distant, but not impossible

While the complete regeneration of a human limb remains, at this stage, a very distant theoretical horizon, this research nonetheless provides a solid foundation for future work on wound healing and tissue repair in humans. The road between the laboratory salamander and a possible clinical application remains long, but every step of molecular understanding, like this one, brings regenerative medicine a little closer to its boldest ambitions.

By Maxime Marquette, columnist

Columnist's transparency note

How I approached this report

This report is based on the published Nature Communications study and on National Geographic's year-end coverage of major 2025 discoveries, along with outlets specializing in developmental biology. I am not a biologist, and I have relied on direct quotes and summaries provided by the researchers rather than drawing my own conclusions from the raw data.

I have been careful to distinguish, throughout this piece, between what the research has actually demonstrated in salamanders and what remains speculative regarding potential human applications. Wherever a claim touched on future medical use, I checked that the researchers themselves framed it as a long-term possibility rather than an imminent therapy, and I have tried to preserve that same careful framing for readers here, rather than inflating the promise of this early-stage discovery beyond what the underlying data actually support at this point.

Sources

Primary sources

National Geographic France — Nine medical discoveries that marked 2025, including salamander regeneration — 2025

Nature — Regeneration: scientific publications on animal regeneration mechanisms — 2025

Cell Press — Research on regeneration biology and retinoic acid — 2025

Secondary sources

Futura Sciences — Accessible analysis of limb regeneration in amphibians — 2025

Sciences et Avenir — Coverage of discoveries on the axolotl and regenerative medicine — 2025

Science et Vie — Reports on animal regenerative capabilities and their medical implications — 2025